ADAPTIN BIO, INC. (APTN) Executive Compensation
ADAPTIN BIO, INC. (APTN) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APTN
CIK: 1938571
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerTaryn Bostjancic
Audit LocationEast Brunswick, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B3 | 2026-09-10 | — | PROSPECTUS | 0001213900-26-098801 | View SEC Doc Filr Page |
| EFFECT | 2026-09-09 | — | EFFECT Filing | 9999999995-26-002923 | View SEC Doc Filr Page |
| S-1 | 2026-08-28 | — | REGISTRATION STATEMENT | 0001213900-26-095034 | View SEC Doc Filr Page |
| 424B3 | 2026-08-25 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-093549 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-20 | CURRENT REPORT | 0001213900-26-093520 | View SEC Doc Filr Page |
| 424B3 | 2026-08-20 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-092107 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089081 | View SEC Doc Filr Page |
| EFFECT | 2026-07-22 | — | EFFECT Filing | 9999999995-26-002384 | View SEC Doc Filr Page |
| POS AM | 2026-07-21 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-26-080096 | View SEC Doc Filr Page |
| D/A | 2026-06-22 | — | D/A Filing | 0001938571-26-000004 | View SEC Doc Filr Page |
| 424B3 | 2026-06-12 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-068357 | View SEC Doc Filr Page |
| 10-K/A | 2026-06-12 | 2025-12-31 | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-068261 | View SEC Doc Filr Page |
| 424B3 | 2026-05-18 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-058479 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057188 | View SEC Doc Filr Page |
| 8-K | 2026-04-06 | 2026-04-06 | CURRENT REPORT | 0001213900-26-040458 | View SEC Doc Filr Page |
| 10-K | 2026-04-01 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-038568 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-038402 | View SEC Doc Filr Page |
| D/A | 2026-03-23 | — | D/A Filing | 0001938571-26-000003 | View SEC Doc Filr Page |
| D/A | 2026-02-20 | — | D/A Filing | 0001938571-26-000002 | View SEC Doc Filr Page |
| D | 2026-01-05 | — | D Filing | 0001938571-26-000001 | View SEC Doc Filr Page |
| 8-K | 2025-12-23 | 2025-12-22 | CURRENT REPORT | 0001213900-25-125451 | View SEC Doc Filr Page |
| 424B3 | 2025-11-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-25-111384 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-110559 | View SEC Doc Filr Page |
| 424B3 | 2025-10-07 | — | PROSPECTUS SUPPLEMENT | 0001213900-25-097028 | View SEC Doc Filr Page |
| 8-K | 2025-10-06 | 2025-10-03 | CURRENT REPORT | 0001213900-25-096532 | View SEC Doc Filr Page |